top of page

San Diego's Alterome Therapeutics raised a $132M Series B today for its precision oncology platform

Co-Founder and CEO Eric Murphy describes what it was like raising the money in this environment, and delves into Alterome's programs, including AKT1 E17K and KRAS.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page